Company: LENZ
Filing Date: 2025-04-04
Form Type: S-3
Source: 0001628280-25-016818
Chunk: 32

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-04
Form: S-3
Chunk 32
---
ifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Solana Beach, State of California, on April 4, 2025.

| LENZ THERAPEUTICS, INC. |     |                           |
| By:                     |     | /s/ Evert Schimmelpennink |
|                         |     | Evert Schimmelpennink     |
|                         |     | Chief Executive Officer   |

### POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Evert Schimmelpennink and Daniel Chevallard, and each of them, as his or her true and lawful attorney-in-fact and agent with full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments and registration statements filed pursuant to Rule 462 under the Securities Act of 1933, as amended), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact, proxy and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact, proxy and agent, or his or her substitute, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:

| Signature                 
 /s/ Evert Schimmelpennink |     | Title                                           
 Chief Executive Officer, President and Director 
 (Principal Executive Officer)                   |     | Date          
 April 4, 2025 |
|:--------------------------|:----|:------------------------------------------------|:----|:--------------|
| Evert Schimmelpennink     |     |                                                 |     |               |
| /s/ Daniel Chevallard     |     | Chief Financial Officer                         
 (Principal Financial and Accounting Officer)    |     | April 4, 2025 |
| Daniel Chevallard